logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
N

Nicholas Kitchin

Pfizer Ltd.
H指数:25
被引数:2.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immunogenicity, Tolerability, and Safety of BA.1-Adapted BNT162b2 Vaccine in 18- to 55-Year-Olds Previously Vaccinated with BNT162b2 or Who Were COVID-19 Vaccine-Naive

BA.1适配型BNT162b2疫苗在18至55岁先前接种过BNT162b2或COVID-19疫苗-naive人群中的免疫原性、耐受性和安全性

Infectious Diseases and Therapy
IF5.3
2026-07-250
OA
David Fitz-Patrick; Omair Sahgal; Leon F. Fouché; Essack Mitha; Mookho Malahleha; Juleen Gayed; Georgina Keep; Ying Zhang; Kayvon Modjarrad; Todd Belanger; Xia Xu; David Cooper; Federico J. Mensa; Uǧur Sahin; Ӧzlem Türeci; Kena A. Swanson; Annaliesa S. Anderson; Alejandra Gurtman; Nicholas Kitchin
Safety and Immunogenicity of the BNT162b2 COVID-19 Vaccine in Immunocompromised Participants 2 Years and Older: Results of an Open-Label Phase 2b Study

BNT162b2 COVID-19疫苗在2岁及以上免疫受损受试者中的安全性和免疫原性：一项开放标签IIb期研究的结果

Vaccines
IF3.4
2026-07-090
OA
Alpana Waghmare; Rucha Dadhe; Robin Kobbe; Lara Danziger-Isakov; Eduardo Sprinz; Flor M. Muñoz; Juleen Gayed; Rohit Solan; Oyeniyi Diya; Bisrat Abraham; Ye Feng; Xia Xu; Todd Belanger; Federico J. Mensa; Roxie Girardin; Özlem Türeci; Uğur Şahin; Kayvon Modjarrad; Kena A. Swanson; Annaliesa S. Anderson; Alejandra Gurtman; Nicholas Kitchin
Randomized Phase 3 Comparison of a 2-Dose and 3-Dose Regimen of a Detoxified Toxin A/B Clostridioides difficile Vaccine in Adults 50 Years and Older

随机化III期比较：针对50岁及以上成人使用的去毒化的产气荚膜梭菌A/B毒素疫苗的2剂和3剂免疫程序

Open Forum Infectious Diseases
IF3.8
2026-05-190
OA
Gretchen Crook; Erik Lamberth; Stephen P Lockhart; Francine Lowry; Haiying Zhang; Yahong Peng; Kenneth Koury; Warren V Kalina; Michael W Pride; Annaliesa S Anderson; William C Gruber; Nicholas Kitchin; null
Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old

奥密克戎BA.1适配的BNT162b2新冠疫苗第四剂在18-55岁成年人中的安全性与免疫原性

Clinical Infectious Diseases
IF7.3
2026-02-010
PRE
Winokur, Patricia; Diya, Oyeniyi; Fitz-Patrick, David; Dever, Michael; Gayed, Juleen; Lockhart, Stephen; Xu, Xia; Zhang, Ying; Bangad, Vishva; Wadsworth, L. Tyler; Cannon, Kevin; Cardona, Jose F.; Usdan, Lisa; Ginis, John; Mensa, Federico J.; Zou, Jing; Xie, Xuping; Lu, Claire; Buitrago, Sandra; Scully, Ingrid L.; Cooper, David; Koury, Kenneth; Jansen, Kathrin U.; Tureci, Ozlem; Sahin, Ugur; Swanson, Kena A.; Gruber, William C.; Kitchin, Nicholas
Safety and Immunogenicity of Monovalent Omicron KP.2-Adapted BNT162b2 COVID-19 Vaccine in Adults: Single-Arm Substudy from a Phase 2/3 Trial

单剂量奥密克戎KP.2变异株适应型BNT162b2 COVID-19疫苗在成人中的安全性与免疫原性：一项II/III期临床试验的单臂亚组研究

Infectious Diseases and Therapy
IF5.3
2025-07-010
OAAI
Oyeniyi Diya; Juleen Gayed; Francine S. Lowry; Hua Ma; Vishva Bangad; Federico Mensa; Jing Zou; Xuping Xie; Yanping Hu; Mark Cutler; Todd Belanger; David Cooper; Xia Xu; Robin Mogg; Özlem Türeci; Uǧur Şahin; Kena A. Swanson; Kayvon Modjarrad; Annaliesa S. Anderson; Alejandra Gurtman; Nicholas Kitchin
A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults

一项1/2期随机研究，旨在评估核苷修饰信使RNA流感疫苗在健康成人中的安全性、耐受性和免疫原性。

VACCINES
IF3.4
2025-04-030
OA
Branche, Angela; Mulligan, Mark J.; Maniar, Alok; Puente, Orlando; Oladipupo, Islamiat; Crowther, Graham; Zareba, Agnieszka M.; Yi, Zhuobiao; Scully, Ingrid; Gomme, Emily; Koury, Kenneth; Kitchin, Nicholas; Allen, Pirada Suphaphiphat; Anderson, Annaliesa S.; Gurtman, Alejandra; Lindert, Kelly
A phase 2/3 trial to investigate the safety and immunogenicity of monovalent Omicron JN.1-adapted BNT162b2 COVID-19 vaccine in adults ≥18 years old

一项2/3期临床试验，旨在研究单价新冠病毒奥密克戎JN.1变异株适应型BNT162b2疫苗在≥18岁成人中的安全性和免疫原性。

VACCINE
IF3.5
2025-04-010
OAAI
Diya, Oyeniyi; Gayed, Juleen; Lowry, Francine S.; Ma, Hua; Bangad, Vishva; Mensa, Federico; Zou, Jing; Xie, Xuping; Hu, Yanping; Cutler, Mark; Belanger, Todd; Cooper, David; Xu, Xia; Koury, Kenneth; Tuereci, Oezlem; Sahin, Ugur; Swanson, Kena A.; Modjarrad, Kayvon; Anderson, Annaliesa S.; Gurtman, Alejandra; Kitchin, Nicholas
Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age

在 ≥ 65岁的成年人中同时施用和联合施用二价BNT162b2新型冠状病毒肺炎疫苗和二价RSVpreF呼吸道合胞病毒疫苗 (含或不含四价流感疫苗) 的安全性和免疫原性

VACCINES
IF3.4
2025-02-050
OAAI
Neutel, Joel M.; Erdem, Rahsan; Jiang, Qin; Cannon, Kevin; Stacey, Helen; Newton, Ryan; Gomme, Emily; Li, Wen; Mensa, Federico J.; Tureci, Ozlem; Sahin, Ugur; Swanson, Kena A.; Munjal, Iona; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S.; Gurtman, Alejandra; Kitchin, Nicholas
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of Clostridioides difficile Infection

三叶草 (艰难梭菌疫苗功效试验) 研究: 一项3期随机试验，研究解毒毒素A/B疫苗在50岁及以上艰难梭菌感染风险增加的成年人中的功效和安全性

CLINICAL INFECTIOUS DISEASES
IF7.3
2024-08-243
OAAI
Donskey, Curtis J.; Dubberke, Erik R.; Klein, Nicola P.; Liles, Elizabeth G.; Szymkowiak, Katarzyna; Wilcox, Mark H.; Lawrence, Jody; Bouguermouh, Salim; Zhang, Haiying; Koury, Kenneth; Bailey, Ruth; Smith, Helen M.; Lockhart, Stephen; Lamberth, Erik; Kalina, Warren V.; Pride, Michael W.; Webber, Chris; Anderson, Annaliesa S.; Jansen, Kathrin U.; Gruber, William C.; Kitchin, Nicholas
Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial

针对XBB.1.5，BA.2.86和JN.1亚系的单价Omicron XBB.1.5适应的BNT162b2新型冠状病毒肺炎疫苗的免疫原性: 2/3期试验

VACCINES
IF3.4
2024-07-024
OAAI
Gayed, Juleen; Bangad, Vishva; Xu, Xia; Mensa, Federico; Cutler, Mark; Tureci, Ozlem; Sahin, Ugur; Modjarrad, Kayvon; Swanson, Kena A.; Anderson, Annaliesa S.; Gurtman, Alejandra; Kitchin, Nicholas
Safety and Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine in Individuals ≥12 Years Old: A Phase 2/3 Trial

单价Omicron XBB.1.5适应的BNT162b2新型冠状病毒肺炎疫苗在 ≥ 12岁个体中的安全性和免疫原性: 2/3期试验

VACCINES
IF3.4
2024-01-2421
OAAI
Gayed, Juleen; Diya, Oyeniyi; Lowry, Francine S.; Xu, Xia; Bangad, Vishva; Mensa, Federico; Zou, Jing; Xie, Xuping; Hu, Yanping; Lu, Claire; Cutler, Mark; Belanger, Todd; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S.; Tureci, Ozlem; Sahin, Ugur; Swanson, Kena A.; Modjarrad, Kayvon; Gurtman, Alejandra; Kitchin, Nicholas
A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in ≥12-Year-Olds

在 ≥ 12岁的儿童中使用二价Omicron-BA.4/BA.5适应的BNT162b2助推器

CLINICAL INFECTIOUS DISEASES
IF7.3
2023-11-288
OAAI
Usdan, Lisa; Patel, Sohil; Rodriguez, Hector; Xu, Xia; Lee, Dung-Yang; Finn, Daniel; Wyper, Hayley; Lowry, Francine S.; Mensa, Federico J.; Lu, Claire; Cooper, David; Koury, Kenneth; Anderson, Annaliesa S.; Tureci, Ozlem; Sahin, Ugur; Swanson, Kena A.; Gruber, William C.; Kitchin, Nicholas
Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age

BNT162b2新型冠状病毒肺炎疫苗在5岁以下儿童中的应用评价

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-02-1645
OAAI
Munoz, Flor M.; Sher, Lawrence D.; Sabharwal, Charu; Gurtman, Alejandra; Xu, Xia; Kitchin, Nicholas; Lockhart, Stephen; Riesenberg, Robert; Sexter, Joanna M.; Czajka, Hanna; Paulsen, Grant C.; Maldonado, Yvonne; Walter, Emmanuel B.; Talaat, Kawsar R.; Englund, Janet A.; Sarwar, Uzma N.; Hansen, Caitlin; Iwamoto, Martha; Webber, Chris; Cunliffe, Luke; Ukkonen, Benita; Martinez, Silvina N.; Pahud, Barbara A.; Munjal, Iona; Domachowske, Joseph B.; Swanson, Kena A.; Ma, Hua; Koury, Kenneth; Mather, Susan; Lu, Claire; Zou, Jing; Xie, Xuping; Shi, Pei-Yong; Cooper, David; Tuereci, Oezlem; Sahin, Ugur; Jansen, Kathrin U.; Gruber, William C.
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years

55岁以上成人的二价Omicron BA.1适应BNT162b2助推器

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-01-1973
OAAI
Winokur, P.; Gayed, J.; Fitz-Patrick, D.; Thomas, S. J. J.; Diya, O.; Lockhart, S.; Xu, X.; Zhang, Y.; Bangad, V; Schwartz, H. I. I.; Denham, D.; Cardona, J. F. F.; Usdan, L.; Ginis, J.; Mensa, F. J. J.; Zou, J.; Xie, X.; Shi, P. -Y; Lu, C.; Buitrago, S.; Scully, I. L. L.; Cooper, D.; Koury, K.; Jansen, K. U. U.; Tureci, O.; Sahin, U.; Swanson, K. A. A.; Gruber, W. C. C.; Kitchin, N.
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2022-01-06432
OAAI
Walter, E. B.; Talaat, K. R.; Sabharwal, C.; Gurtman, A.; Lockhart, S.; Paulsen, G. C.; Barnett, E. D.; Munoz, F. M.; Maldonado, Y.; Pahud, B. A.; Domachowske, J. B.; Simoes, E. A. F.; Sarwar, U. N.; Kitchin, N.; Cunliffe, L.; Rojo, P.; Kuchar, E.; Ramet, M.; Munjal, I; Perez, J. L.; Frenck, R. W., Jr.; Lagkadinou, E.; Swanson, K. A.; Ma, H.; Xu, X.; Koury, K.; Mather, S.; Belanger, T. J.; Cooper, D.; Tureci, O.; Dormitzer, P. R.; Jansen, K. U.; Gruber, W. C.
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2021-10-21276
OAAI
Falsey, Ann R.; Frenck, Robert W., Jr.; Walsh, Edward E.; Kitchin, Nicholas; Absalon, Judith; Gurtman, Alejandra; Lockhart, Stephen; Bailey, Ruth; Swanson, Kena A.; Xu, Xia; Koury, Kenneth; Kalina, Warren; Cooper, David; Zou, Jing; Xie, Xuping; Xia, Hongjie; Tuereci, Ozlem; Lagkadinou, Eleni; Tompkins, Kristin R.; Shi, Pei-Yong; Jansen, Kathrin U.; Sahin, Ugur; Dormitzer, Philip R.; Gruber, William C.

研究方向

暂未获取到该数据
K
Kena A. Swanson
H 指数:47论文数:146被引数:3.2万
U
Uğur Şahin
H 指数:103论文数:733被引数:6.9万
A
Annaliesa S. Anderson
H 指数:53论文数:263被引数:1.2万
W
William C. Gruber
H 指数:76论文数:304被引数:4.2万
Ö
Özlem Türeci
H 指数:80论文数:422被引数:5.5万
K
Kenneth Koury
H 指数:30论文数:115被引数:3.3万
S
Stephen Lockhart
H 指数:31论文数:95被引数:2.6万
A
Alejandra Gurtman
H 指数:40论文数:140被引数:2.7万
D
David Cooper
H 指数:45论文数:122被引数:3.1万
X
Xia Xu
H 指数:38论文数:188被引数:7,558